SNOA icon

Sonoma Pharmaceuticals

20 hedge funds and large institutions have $1.42M invested in Sonoma Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 4 closing their positions.

Holders
20
Holders Change
-3
Holders Change %
-13.04%
% of All Funds
0.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
8
Reduced
3
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$600K 464,397 +65,556 +16%
Goldman Sachs
2
Goldman Sachs
New York
$175K 135,316 +7,010 +5%
BIT
3
BlackRock Institutional Trust
California
$165K 127,617
BRWA
4
B. Riley Wealth Advisors
Florida
$142K 109,303 +15,350 +16%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$86K 67,116 +42,353 +171%
Citadel Advisors
6
Citadel Advisors
Florida
$65K 50,103 +38,663 +338%
GW
7
GW & Wade
Massachusetts
$58K 45,000 +30,000 +200%
NL
8
NWAM LLC
Washington
$31K 24,000
Nomura Holdings
9
Nomura Holdings
Japan
$31K 23,800 +2,800 +13%
Northern Trust
10
Northern Trust
Illinois
$26K 19,526 +19,526 New
Morgan Stanley
11
Morgan Stanley
New York
$17K 13,632 -24,835 -65%
Wells Fargo
12
Wells Fargo
California
$9K 6,371
Bank of America
13
Bank of America
North Carolina
$8K 6,200 +4,000 +182%
Bank of Montreal
14
Bank of Montreal
Ontario, Canada
$4K 2,820
JFGIW
15
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$2K 1,571
LTFS
16
Ladenburg Thalmann Financial Services
Florida
$1K 842
MFS
17
MSI Financial Services
Massachusetts
$1K 442
Jane Street
18
Jane Street
New York
-54,756 Closed
Deutsche Bank
19
Deutsche Bank
Germany
-18,800 Closed
Barclays
20
Barclays
United Kingdom
-17,995 Closed
FANJ
21
Financial Architects (New Jersey)
New Jersey
-6,100 Closed
UBS Group
22
UBS Group
Switzerland
$0 185 -4,486 -96%
Citigroup
23
Citigroup
New York
$0 171 -1,987 -92%
AF
24
Allworth Financial
California
$0 314
TRCT
25
Tower Research Capital (TRC)
New York